-transparent.png){kind=logo}
Using two immunogenic methylcholanthrene-induced fibrosarcomas in CD2F1 male mice, initial observations suggested that the rate of tumor growth might be enhanced by castration. For confirmation, tumor transplantation experiments using more than 500 mice were carried out in order to compare tumor specific transplantation immunity in castrate and in control male mice. Inbred mice bearing a 3-methylcholanthrene-induced fibrosarcoma transplant underwent surgical excision of the tumor; and specific resistance to subsequent challenges using varying doses of that tumor cell line were compared in castrate and in noncastrate groups of mice. Although castration influenced the rate of tumor growth, castration had no apparent effect on tumor specific immunoresistance. Mechanisms of host-tumor immunorelationships are discussed.
G E Brannen, and
D M Gomolka, and
J N Wettlaufer, and
R O Modarelli
December 1978,
National Cancer Institute monograph,
G E Brannen, and
D M Gomolka, and
J N Wettlaufer, and
R O Modarelli
April 1983,
Journal of clinical & laboratory immunology,
G E Brannen, and
D M Gomolka, and
J N Wettlaufer, and
R O Modarelli
May 1990,
The Journal of surgical research,
G E Brannen, and
D M Gomolka, and
J N Wettlaufer, and
R O Modarelli
January 1976,
Advances in pathobiology,
G E Brannen, and
D M Gomolka, and
J N Wettlaufer, and
R O Modarelli
August 1971,
The Journal of surgical research,
G E Brannen, and
D M Gomolka, and
J N Wettlaufer, and
R O Modarelli
January 1970,
Zeitschrift fur Krebsforschung,
G E Brannen, and
D M Gomolka, and
J N Wettlaufer, and
R O Modarelli
January 1973,
Cancer,
G E Brannen, and
D M Gomolka, and
J N Wettlaufer, and
R O Modarelli
January 1975,
Oncology,
G E Brannen, and
D M Gomolka, and
J N Wettlaufer, and
R O Modarelli
September 1990,
Journal of the National Cancer Institute,
G E Brannen, and
D M Gomolka, and
J N Wettlaufer, and
R O Modarelli
August 2016,
Annals of translational medicine,
